Skip to content
My WebMD Sign In, Sign Up

Heart Failure Health Center

Font Size
A
A
A

Medication Shows Promise for Treating Severe Heart Failure

continued...

The findings add to previously reported favorable effects of carvedilol in patients with mild and moderate degrees of heart failure. Additionally, two other drugs in the beta-blocker class, metoprolol and bisoprolol, have been shown to reduce the risk of premature death in patients with mild and moderate heart failure.

However, Packer cautions against assuming that the COPERNICUS results apply to all beta-blocker medications. Even so, he adds, the favorable results obtained with metoprolol and bisoprolol give physicians at least three choices among beta-blockers for treatment of mild and moderate heart failure.

The findings from COPERNICUS should encourage physicians to prescribe beta-blockers more often in the treatment of heart failure, says Packer. Prior to COPERNICUS, heart failure authorities estimated that 75-80% of heart failure patients should be receiving a beta-blocker, but available data suggest that no more than 10-20% of heart failure patients are actually prescribed one of these medications.

"We hope the results of COPERNICUS will not only apply to severe heart failure but will get physicians to bring up the overall percentage of beta-blocker use from where it is now to where it should be," he says.

 

1 | 2

Today on WebMD

Man holding hand on chest
SLIDESHOW
Salt Shockers
Slideshow
 
Inside A Heart Attack
Slideshow
lowering blood pressure
SLIDESHOW
 

Mechanical Heart
Article
Omega 3 Overview Slideshow
Slideshow
 
Atrial Fibrillation Guide
Slideshow
Simple Steps to Lower Cholesterol
Slideshow
 

Compressed heart
Article
FAQ Heart Failure
Article
 
Cholesterol Confusion
Health Check
Resolved To Quit Smoking
Slideshow
 

WebMD Special Sections